Concepedia

Jiang Zhu

JZ

Statistics

Publications

10

Citations

262

H-Index

10

Active since

2013

Affiliations

Principia Biopharma (United States)(Current)

Sichuan Cancer Hospital

Xiangyang Central Hospital

First People’s Hospital of Jingmen

Xian Yang Central Hospital

Jiang Zhu is an author at Principia Biopharma (United States) specializing in medicine, radiation oncology, and oncology.

ORCID

Top concepts

Publications per year

2013–2022

10

Publications

10

Discovery of Reversible Covalent Bruton’s Tyrosine Kinase Inhibitors PRN473 and PRN1008 (Rilzabrutinib)

Timothy D. Owens, Ken A. Brameld, Erik Verner et al. · Journal of Medicinal Chemistry · 2022 · 65 citations · Full text

Telmisartan Exerts Anti-Tumor Effects by Activating Peroxisome Proliferator-Activated Receptor-γ in Human Lung Adenocarcinoma A549 Cells

Juan Li, Lin Chen, Ping Yu et al. · Molecules · 2014 · 41 citations · Full text

, , +20

A phase I trial of PD-1 deficient engineered T cells with CRISPR/Cas9 in patients with advanced non-small cell lung cancer.

You Lü, Jianxin Xue, Tao Deng et al. · Journal of Clinical Oncology · 2018 · 30 citations

, , +19

Downregulated Expression of the Cyclase-associated Protein 1 (CAP1) Reduces Migration in Esophageal Squamous Cell Carcinoma

Min Li, Xi Yang, Haiyun Shi et al. · Japanese Journal of Clinical Oncology · 2013 · 29 citations · Full text

PRN1008, a Reversible Covalent BTK Inhibitor in Clinical Development for Immune Thrombocytopenic Purpura

Claire L. Langrish, J. Michael Bradshaw, Timothy D. Owens et al. · Blood · 2017 · 18 citations

1–5 of 10